Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME

Status unconfirmed · Phase 4

Conditions studied: Diabetic Macular Edema, Diabetic Retinopathy, Retinal Ischemia

In brief

The objective of this study is to test the hypothesis that following the use of intravitreal dexamethasone implant for the treatment of DME, there will be an observable increase in the capillary density plexus as denoted by the quantitative assessment of the superficial capillary plexus on OCTA, as well as a decrease in size of the foveal avascular zone (FAZ).

Key facts

Study ID
NCT04038125
Run by
Retina Macula Specialists of Miami, LLC
People needed
20
Starts
2019-08-22
Expected to finish
2021-08-01
Last updated by the study team
2020-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.